GOLGA5P1

Across TCGA pan-cancer cohorts, GOLGA5P1 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of GOLGA5P1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where GOLGA5P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types GOLGA5P1 is over-expressed in tumor, although a few such as COAD and THCA show the opposite, repressed pattern.

KIRC, STAD, and COAD are the cancer types where GOLGA5P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GOLGA5P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	+0.077	<.001	10	view →
STAD	All	All	+0.228	<.001	5	view →
COAD	All	All	−0.052	.004	4	view →
BRCA	Female	All	+0.067	.031	2	view →
HNSC	Male	All	+0.045	.036	2	view →
ESCA	Female	All	+0.220	.047	1	view →
THCA	Female	All	−0.029	.038	1	view →
LIHC	Female	II,III,IV	+0.028	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

GOLGA5P1–KIRC

Open the KIRC breakdown →